Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Kala K. Blakely"'
Publikováno v:
The Journal for Nurse Practitioners. 18:636-639
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::82b0a90f5af3984e72a38f22fdbc6b64
https://doi.org/10.1016/j.nurpra.2022.02.019
https://doi.org/10.1016/j.nurpra.2022.02.019
Autor:
Kendra Weaver, Kala K. Blakely
Publikováno v:
Nursing for Women's Health. 24:370-376
Semaglutide is an oral glucagon-like peptide receptor agonist approved in 2019 by the U.S. Food and Drug Administration. It is marketed under the brand name Rybelsus and was approved to be used in conjunction with lifestyle modifications to treat ind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::781a7614899e5eb3c106be65061a9368
https://doi.org/10.1016/j.nwh.2020.07.005
https://doi.org/10.1016/j.nwh.2020.07.005
Autor:
Kala K. Blakely, Kelley Stallworth
Publikováno v:
Nursing for Women's Health. 24:294-299
Lasmiditan is a new oral medication for treatment of acute migraine. It was approved by the U.S. Food and Drug Administration in October 2019 and is marketed under the brand name Reyvow (Eli Lilly and Company, Indianapolis, IN). It is the first of it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02a9e3129aa244aaa0901f5d3d4eef05
https://doi.org/10.1016/j.nwh.2020.05.008
https://doi.org/10.1016/j.nwh.2020.05.008
Publikováno v:
Nursing for Women's Health. 24:45-51
Measles (rubeola) was once nearly eradicated in the United States. Unfortunately, it has reappeared, with more than three times the number of confirmed cases in 2019 than in 2018. The virus, which produces a distinct rash that appears within days of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::376aea625fc2e42a46341a0cbfe82e2c
https://doi.org/10.1016/j.nwh.2019.11.005
https://doi.org/10.1016/j.nwh.2019.11.005
Autor:
Kala K. Blakely, Cori Johnson
Publikováno v:
Nursing for Women's Health. 24:52-57
The U.S. Food and Drug Administration approved romosozumab as a new osteoporosis drug in April 2019. Marketed under the brand name Evenity (Amgen, Thousand Oaks, CA), it is a sclerostin inhibitor that promotes new bone formation. It is the first in i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba01e706b53b17488b0ab9130c758929
https://doi.org/10.1016/j.nwh.2019.11.002
https://doi.org/10.1016/j.nwh.2019.11.002
Autor:
Natalie R. Baker, Kala K. Blakely
Publikováno v:
The Journal for Nurse Practitioners. 19:104415
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a892bf044cde5ac241203885a2d00cc
https://doi.org/10.1016/j.nurpra.2022.07.023
https://doi.org/10.1016/j.nurpra.2022.07.023
Autor:
Kala K. Blakely, Natalie R. Baker
Publikováno v:
The Journal for Nurse Practitioners. 19:104390
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a77b5fc7526fa500086aa54a288ad6db
https://doi.org/10.1016/j.nurpra.2022.06.015
https://doi.org/10.1016/j.nurpra.2022.06.015
Autor:
Doreen C. Harper, Aimee Chism Holland, Maria R. Shirey, Joy P Deupree, Kala K. Blakely, LaCretia Plane, Cynthia S. Selleck, Ashley L. Hodges
Publikováno v:
The Journal for Nurse Practitioners. 15:e69-e72
This report describes an innovative curriculum designed to prepare nurse practitioners (NPs) to bridge primary care access gaps in rural Alabama. The University of Alabama at Birmingham School of Nursing developed a sustainable curriculum that educat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8429afec91b8536cd19e08c3b823f09
https://doi.org/10.1016/j.nurpra.2018.12.021
https://doi.org/10.1016/j.nurpra.2018.12.021
Autor:
Kala K. Blakely
Publikováno v:
Nursing for Women's Health. 23:172-176
The U.S. Food and Drug Administration approved a new combination hormonal contraceptive in August 2018. Sold under the brand name Annovera, it is a combination of segesterone acetate and ethinyl estradiol, and it is the first multiuse vaginal contrac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24640067f2241e7be48cb51594c74718
https://doi.org/10.1016/j.nwh.2019.01.008
https://doi.org/10.1016/j.nwh.2019.01.008
Publikováno v:
Nursing for women's health. 24(5)
In 2019, the U.S. Food and Drug Administration approved cefiderocol, a new treatment option for individuals with complicated urinary tract infections. Cefiderocol is a cephalosporin antibiotic indicated for use in adults 18 years or older who have mi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::846d96d7b35d41a3bc010936a588d14a
https://pubmed.ncbi.nlm.nih.gov/32890463
https://pubmed.ncbi.nlm.nih.gov/32890463